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Background: Clarithromycin (CAM), a representative macrolide antibiotic, has been used widely at low doses for
long-term therapy of chronic inflammatory airway diseases. Anti-inflammatory effects of macrolide antibiotics were
first discovered in clinical practice. Although oxidative stress is known as a key pathogenesis factor in chronic
airway inflammatory diseases, the mechanism of action of low-dose, long-term CAM therapy remains unclear. We
aimed to examine the cytoprotective action of CAM against hydrogen peroxide (H2O2)-induced cell dysfunction,
focusing on CAM dose and treatment duration, and using human small airway epithelial cells (SAECs), the main
cells involved in chronic airway inflammatory diseases.
Methods: SAECs were pretreated with CAM (1, 5 or 10 μM) for 24, 48 or 72 h, and were subsequently exposed to
H2O2 for 0.5–4 h. Levels of interleukin (IL)-8, glutathione (GSH) and glutathione disulfide (GSSG), and the activities of
nuclear factor (NF)-κB and γ-glutamylcysteine synthetase (γ-GCS) were assayed using specific methods. IL-8 mRNA
and NF erythroid 2-related factor 2 (Nrf2) mRNA expression were measured using real-time reverse transcription
polymerase chain reaction (RT-PCR). Tukey’s multiple comparison test was used for analysis of statistical significance.
Results: Pretreatment with low-dose (1 or 5 μM), long-term (72 h) CAM inhibited H2O2-induced IL-8 levels, NF-κB
activity, and IL-8 mRNA expression, and improved the GSH/GSSG ratio via the maintenance of γ-GCS expression
levels. Similar to its enhancing effect on the GSH/GSSG ratio, pretreatment with low-dose CAM for 72 h significantly
increased Nrf2 mRNA expression (p < 0.01 and p < 0.05). In contrast, these alterations were not observed after
pretreatment with high-dose (10 μM) or short-term (24 and 48 h) CAM.
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Conclusions: CAM is efficacious against cell dysfunction caused by oxidative stress under low-dose, long-term
treatment conditions. This effect depended on the suppression of NF-κB activation and improvement of the
H2O2-induced oxidant/antioxidant imbalance that is achieved by increasing Nrf2 mRNA expression in SAECs. The
present study may provide the first evidence of why low-dose, long-term administration of macrolides is effective
for treating chronic inflammatory airway diseases.
Keywords: Clarithromycin, Anti-inflammatory effect, Low-dose, Long-term treatment, Human small airway epithelial
cells, Interleukin-8, Nuclear factor-κB, Nuclear factor erythroid 2-related factor 2, Oxidant/antioxidant balance,
γ-Glutamylcysteine synthetaseBackground
Macrolides such as clarithromycin (CAM) have been
reported to be effective for the treatment of chronic
inflammatory airway diseases at low doses and with
long-term administration [1–5]. The effectiveness of
macrolides in treating inflammatory airway diseases has
been thought to be due to immunomodulatory effects
rather than to direct antimicrobial activity. For instance,
both CAM and erythromycin (EM) inhibit the pro-
duction of inflammatory cytokines, such as interleukin
(IL)-6 and IL-8, inhibit the release of soluble intracellular
adhesion molecule (ICAM)-1 from airway epithelial cells,
and decrease airway neutrophil accumulation [6, 7]. How-
ever, there are limited data concerning the potential bene-
fits of low-dose, long-term application of CAM in a
variety of chronic inflammatory airway diseases.
Environment-derived reactive oxygen species (ROS)
are a primary cause of airway inflammation. Cigarette
smoking has been proven to be the most important risk
factor for causing airway oxidative stress [8]. In addition
to external causes, the ROS hydrogen peroxide (H2O2) is
known to increase chronic airway inflammation [9–13].
IL-8 is a neutrophil chemoattractant peptide, and it can
induce polymorphonuclear neutrophil oxidative bursts
that release H2O2 into the airways and lungs [14].
Furthermore, production of IL-8 is mediated by the acti-
vation of transcription factors such as nuclear factor
(NF)-κB. Exposure to a number of stimuli, including
ROS, results in the activation of NF-κB target genes in-
cluding IL-8, and leads to increased synthesis of inflam-
matory proteins in the lung [15, 16]. Similarly, H2O2
induces glutathione (GSH, L-glutamyl-L-cysteinylgly-
cine) production via NF-κB activation in bronchial epi-
thelial and endothelial cells [17–19]. GSH is known to
play an important role in the modulation of the oxidant/
antioxidant balance in bronchial epithelium. Thus, GSH
clears ROS and protects the bronchial epithelium from
oxidative damage. GSH is produced via the activity of
γ-glutamylcysteine synthetase (γ-GCS), an enzyme that
catalyzes the first step and the rate-limiting step in de novo
GSH synthesis [20]. Nuclear factor erythroid 2-relatedfactor 2 (Nrf2) is a transcription factor that plays a key role
in the regulation of γ-GCS expression and activity. Nrf2 is
usually in a resting state in the cytoplasm. However, when
it is stimulated by stresses such as oxidative stress, Nrf2
moves into the nucleus and binds to DNA. This binding
then leads to the expression of various cytoprotective genes
including γ-GCS [21]. Nrf2 thereby maintains intracellular
GSH levels and redox homeostasis and plays an important
role in protecting cells against oxidative damage.
Several reports have described the effect of macrolides
on ROS-induced pulmonary inflammation or airway epi-
thelial cell damage. Mikura et al. [22] and Zhou et al.
[23] demonstrated that erythromycin (EM) prevents the
lung inflammation induced by exposure to cigarette
smoke in mice and rats. Kobayashi et al. [24] demon-
strated that solithromycin (a novel macrolide), CAM,
azithromycin, and telithromycin are protective against
cigarette smoke-induced neutrophilia and IL-8 produc-
tion in bronchoalveolar lavage fluid in mice. In addition
to these in vivo experiments, it has been reported that
the increases in IL-8 and GSH levels induced by H2O2
were abrogated by preincubation of human bronchial
epithelial cells with EM [25]. Moreover, CAM signifi-
cantly reduced soluble ICAM-1 expression induced by
lipopolysaccharide (LPS)-induced oxidative stress in cul-
tured rat tracheal epithelial cells [26]. Nevertheless, it is
believed that these results, which show a concentration-
dependent inhibitory effect after a relatively short
incubation time, are not consistent with the effect of long-
term clinical administration of macrolides at low doses.
In addition to the above data, CAM was observed to
inhibit NF-κB activation in human peripheral blood
mononuclear and pulmonary epithelial cells [27]. Fur-
thermore, CAM suppressed IL-8 production via inhib-
ition of NF-κB in human monocytes [28], while EM also
inhibited GSH production and γ-GCS expression via
inhibition of NF-κB in bronchial epithelial cells [25].
However, another report showed that CAM did not sup-
press NF-κB activation in human bronchial epithelial
cells [29]. Thus, the inhibitory effects of macrolides on
NF-κB activation are controversial. On the other hand, it
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expression but also NF-κB activation [30, 31]. However,
there are no reports describing direct effects of macro-
lides on Nrf2 activity.
The present study was designed to answer the follow-
ing questions: 1) are concentration and incubation time
important factors in mediating the cytoprotective action
of macrolides against H2O2-induced cell dysfunction; 2)
do macrolide antimicrobial agents inhibit H2O2-induced
oxidant/antioxidant imbalance and NF-κB activation;
and 3) is Nrf2 activation involved in the effects of
macrolides on GSH synthesis? Human small airway epi-
thelial cells (SAECs), which are the main cell type
involved in chronic inflammatory airway diseases, were
used as model cells. Furthermore, CAM was used as a
representative macrolide because its clinical efficacy
against respiratory inflammatory disease is relatively
high compared to that of other macrolides [32].
Methods
Chemicals and reagents
CAM, H2O2 (30%), the WST-8 (2-(2-methoxy-4-nitrophe-
nyl)-3-(4-nitrophenyl)-5-(2,4- disulfophenyl)-2H-tetrazolium)
assay system, GSH, and 5,5’-dithiobis(2-nitrobenzoic acid)
(DTNB) were purchased from Wako Pure Chemical
Industries, Ltd. (Osaka, Japan). GSH reductase (from
yeast) and reduced nicotinamide adenine dinucleotide
phosphate (NADPH) were from Oriental Yeast Co., Ltd.
(Tokyo, Japan). Buthionine sulfoximine (BSO) and mouse
anti-β-actin monoclonal antibody were from Sigma
Chemical Co. (St. Louis, MO). A human IL-8 enzyme-
linked immunosorbent assay (ELISA) kit was purchased
from Bender Med Systems (Vienna, Austria). Rabbit poly-
clonal antibody against γ-GCS was from Neomarkers
(Fremont, CA). The nuclear extraction and nuclear tran-
scription factor ELISA kits were from Panomics (Fremont,
CA). Cell culture media were obtained from Lonza
(Walkersville, MD). All other chemicals used were of
reagent grade.
Cell culture and treatment
SAECs, cells of a normal human small airway epithelial
cell line, were purchased from Lonza. SAECs were
cultured in small airway growth medium (SAGM)
supplemented with 0.1% bovine pituitary extract, 0.1%
hydrocortisone, 0.1% insulin, 30 μg/mL gentamicin
(GM), 15 ng/mL amphotericin B (AMTB), 0.1% fatty
acid-free bovine serum albumin, 0.1% retinoic acid, 0.1%
transferrin, 0.1% triiodothyronine, 0.1% epinephrine, and
0.1% human recombinant epidermal growth factor. Cells
were seeded in 75-cm2 filter vent flasks (Corning, NY)
and grown to 80% confluence (3 × 106 cells/well) for
each experimental condition at 37 °C, in a humidified
atmosphere of 5% CO2 and 95% air. The culturemedium was changed on day 1 and subsequently every
2 days. Cells were passaged by trypsinization, and cul-
tures between passages 3 and 9 were used for all experi-
ments. Cells were cultured in the presence or absence of
CAM (1, 5 or 10 μM) for 24–72 h and were then stimu-
lated with H2O2 (100 μM) for an additional 0.5–4 h.
Pretreatments with CAM were carried out with a differ-
ent set of cells for each concentration and treatment
duration. In addition, cell stimulation with H2O2 was
performed as follows in order to determine at which
time the effect of H2O2 treatment was the strongest. For
stimulation of the cells with H2O2, the medium was
changed to small airway basal medium (SABM) contain-
ing no supplements because bovine pituitary extract and
serum may include antioxidants, chelators of transition
metal ions, and high-density lipoproteins [33]. CAM was
dissolved in dimethylsulfoxide at a final concentration of
10 mM, and was then diluted with distilled water or cul-
ture medium to the desired concentrations. The final
dimethylsulfoxide concentration was less than 0.1%.
CAM solution used for experiments was prepared im-
mediately before use.
Cell proliferation and viability
SAECs (3 × 104 cells/well) seeded in collagen-coated
96-well plates were treated with CAM (1, 5, 10 or 30 μM)
for 24, 48 or 72 h or with H2O2 (100, 300 or 500 μM) for
24 h. Post-treatment, the SAEC medium was changed to
basal medium containing 10% WST-8 solution and the
cells were incubated at 37 °C for 2 h. The WST-8 solution
is reduced by living cells to give an orange-colored forma-
zan product with an absorbance at 450 nm. The optical
density (OD) of the culture medium was measured at
450 nm with a spectrophotometric microliter plate reader
(Bio-Rad; Hercules, CA) at 24, 48, and 72 h after treat-
ment. Cell proliferation and viability are expressed as the
ratio of surviving cells to untreated cells. The morphology
of SAECs was evaluated visually throughout the course of
the experiments.
IL-8 protein levels in culture supernatants
SAECs (3 × 104 cells/well) in 96-well plates were pre-
treated with CAM (1, 5 or 10 μM) for 24, 48 or 72 h
and were then stimulated with H2O2 (100 μM) for 4 h.
Culture media supernatants were collected and centri-
fuged to remove cell debris (12,000 × g for 10 min). The
supernatants were frozen at -80 °C until use in assays.
IL-8 protein levels in the culture supernatants were ana-
lyzed using ELISA according to the manufacturer’s in-
structions. Briefly, experimental samples were added
into individual wells coated with human monoclonal
antibody specific for IL-8 and were incubated for 3 h at
room temperature. After six washes with phosphate-
buffered saline (PBS) containing 0.1% Tween 20 to
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added to each well and incubated for 10 min at room
temperature. The reaction was terminated by the addition
of 1 M phosphoric acid. The color generated in each sam-
ple was determined by measurement of OD at 450 nm
using a spectrophotometric microliter plate reader. The
IL-8 protein levels of unknown samples were calculated
using a standard curve. Data are expressed as means ± SD
in pg/ml culture supernatants. This assay was specific for
human IL-8 and the antibody did not cross-react with
IL-6, IL-2R, recombinant human lymphotoxin (rhTNFβ),
or CD8 antigen. Assay sensitivity was 1.3 pg/ml and intra-
and inter-assay variations were less than 8.1%.IL-8 mRNA expression
SAECs (106 cells/well) in 6-well plates were pretreated
with CAM (1, 5 or 10 μM) for 24, 48, or 72 h and were
then stimulated with H2O2 (100 μM) for 1 h. Total RNA
was obtained using a PureLink RNA Mini Kit (Life
Technologies Corp., Carlsbad, CA, USA) following the
manufacturer’s instructions and was quantified by meas-
urement of absorbance at 260 nm. RNA (2 μg) was re-
verse transcribed into complementary deoxyribonucleic
acid (cDNA) using a SuperScript VILO cDNA Synthesis
Kit following the manufacturer’s instructions. TaqMan
polymerase chain reaction (PCR) primers and probes for
IL-8 and for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as the internal standard gene were purchased
from Applied Biosystems (Foster City, CA). TaqMan
PCR was performed with 1 μl of sample cDNA in a
20-μl reaction mixture containing TaqMan gene master
mix and TaqMan gene expression assay. Amplification
was performed using the 7500 Real Time Reverse
Transcription-PCR System (Applied Biosystems). The
PCR thermal protocol consisted of 50 °C for 2 min and
95 °C for 10 min, followed by 40-cycle amplification at
95 °C for 15 s and 60 °C for 1 min. Relative quantification
of gene expression was performed using the comparative
threshold method. Changes in mRNA expression were
calculated after normalizing to GAPDH, and are expressed
as a ratio to changes in untreated cells.Extraction of nuclear proteins and transcription factor
assay
SAECs (106 cells/well) in 6-well plates were pretreated
with CAM (1, 5 or 10 μM) for 24, 48 or 72 h and were
then stimulated with H2O2 (100 μM) for 1 h. Cells were
washed with ice-cold PBS and nuclear extracts were ob-
tained using a nuclear extraction kit according to the
manufacturer’s instructions (Panomics Co. Fremont, CA).
Nuclear protein was measured using the DC protein assay
(Bio-Rad) and a 10 μg aliquot of nuclear protein was ap-
plied to a Transcription Factor ELISA kit to assay NF-κB.Western blot analysis for IκBα phosphorylation and γ-GCS
protein
Phosphorylated inhibitor κBα (p-IκBα) and γ-GCS pro-
tein levels were analyzed by western blotting. SAECs
(2 × 106 cells/well) in 6-cm dishes were pretreated with
CAM (1, 5 or 10 μM) for 72 h and were then stimulated
with H2O2 (100 μM) for 0.5 h for p-IκBα and 1 h for γ-
GCS analysis. Cells were washed with Dulbecco’s
phosphate-buffered saline (DPBS) and were collected
using fresh DPBS and a cell scraper. After centrifugation
at 2000 × g for 10 min, 50 μl of radioimmunoprecipita-
tion assay buffer (Pierce, Rockford, IL) containing 1 M
vanadate and protease inhibitors was added and then
cell pellets were sonicated three times for 10 s each time.
The lysates were centrifuged at 12,000 × g for 10 min
and then an aliquot of the supernatant containing 10 μg
of protein was resuspended in an equal amount of sam-
ple buffer (Laemmli sample buffer containing 0.5 mM of
2-mercaptoethanol) and was boiled for 5 min. Protein
concentration was assayed using the same method as
that used for the GSH and GSSG assays that are de-
scribed in the following experiment. Samples that had
been refrigerated were separated by 12% sodium dodecyl
sulfate polyacrylamide gel electrophoresis, and the gel
was then electrotransferred onto a nitrocellulose mem-
brane (Bio-Rad). Membranes were blocked in 5% nonfat
dry milk in a Tris-buffered solution containing 0.1%
Tween 20 at room temperature for 2 h. The membrane
was incubated with primary antibodies for p-IκBα, γ-
GCS or β-actin with horseradish peroxidase-conjugated
secondary antibodies. Signal was detected as the inten-
sity of chemiluminescence using an ECL Plus Western
Blotting Detection Kit (GE Healthcare, Buckingham-
shire, UK). p-IκBα or γ-GCS levels were normalized to
constitutive expression of β-actin protein, and are
expressed as p-IκBα/β-actin or γ-GCS/β-actin calculated
as the scan unit ratio (%) ± SD of four experiments.
Measurement of GSH and GSSG levels
Intracellular GSH and GSSG levels were measured using
the DTNB recycling method [34]. SAECs (5 × 105 cells/well)
in 12-well plates were pretreated with CAM (1, 5 or 10 μM)
for 72 h and were then stimulated with H2O2 (100 μM)
for 2 h. The cells were washed with DPBS and solubilized
with 220 μl of PBS containing 0.1% Triton X-100. After
centrifugation, cell supernatants were collected and used
as the total GSH (GSH and GSSG) sample. To obtain the
GSSG sample, an aliquot of the supernatant (100 μl) was
mixed with 2-vinylpyridine (2.4 μl) and the mixture was
adjusted to pH 6.8 with 0.1 M sulfuric acid (4.8 μl). The
solution was mixed vigorously for 1 min and incubated at
25 °C for 20 min. Each sample was then used for total
GSH or GSSG assay by adding 0.2 mM NADPH, 0.6 mM
DTNB and GSH reductase (1.3 U/ml), and the 2-nitro-5-
Iwayama et al. BMC Pharmacology and Toxicology  (2017) 18:15 Page 5 of 15thiobenzoic acid produced by the samples was measured
spectrophotometrically (Hitachi Co., Tokyo, Japan) at
412 nm for 5 min. GSH was calculated by determination
of the difference between total GSH and GSSG levels. Pro-
tein concentration was determined using the Bradford
method with bovine serum albumin as the standard. Data
are expressed as the GSH/GSSG ratio ± SD of four
experiments.
Nrf2 mRNA expression
Nrf2 mRNA expression in SAECs was examined to de-
termine if CAM directly affects Nrf2 activity. SAECs
(106 cells/well) in 6-well plates were pretreated with
CAM (1, 5 or 10 μM) for 72 h and were then stimulated
with H2O2 (100 μM) for 1 h. Nrf2 mRNA expression
was measured using the same method as that used for
measurement of IL-8 mRNA expression, except that
TaqMan PCR primers and probes for Nrf2 instead of for
IL-8 were used.
Cell viability following BSO treatment
SAECs (3 × 104 cells/well) in 96-well plates were
pretreated with BSO (1 mM) for 16 h and were then
stimulated with H2O2 (100 μM) for 1, 3 or 6 h. For com-
parison, cells were pretreated with CAM (1, 5 or 10 μM)
for 72 h and were then stimulated with H2O2 (100 μM) for
3 h. After the H2O2 treatment, cell viability was evaluated
using the WST-8 assay method as described above.
Measurement of intracellular ROS levels
Intracellular ROS levels were measured using flow cy-
tometry with 5 (and 6)-carboxy-2’, 7’-dichlorofluorescein
diacetate (CDF) as a fluorescent probe of intracellular
ROS. SAECs (5 × 105 cells/well) in 12-well plates were
pretreated with CAM (1, 5 or 10 μM) for 72 h and were
then treated with CDF (1 μM) for 0.25 h before stimula-
tion with H2O2 (100 μM) for 0.25 h. After the H2O2
treatment, the cells were washed with DPBS and were
then filtered through a nylon mesh (35 μm). The fluores-
cence intensity of CDF in the obtained sample was mea-
sured at 488 nm (excitation wavelength) and 530 nm
(fluorescence wavelength) using a flow cytometer (Beckman
Coulter Inc., Brea, CA).
Measurements of extra- and intracellular CAM
concentrations using HPLC
To evaluate CAM concentrations in culture superna-
tants and within cells, SAECs were cultured for 24, 48
or 72 h with CAM. Cell treatments and sample prepar-
ation were performed according to the method described
by Togami et al. [35]. Briefly, SAECs were suspended in
SAGM at a density of 106 cells/ml. The cell suspension
was seeded into 96-well plates and incubated for 48 h.
After this incubation, the cells were treated with CAM(1, 5 or 10 μM) for 24, 48 or 72 h. SAECs were collected
by centrifugation. The cell pellets were washed three
times with ice-cold PBS to remove any unbound CAM
and were then solubilized with a solution of 0.1 M
NaOH. These cell lysates (equivalent of 106 cells/ml)
were used as intracellular samples. The supernatants
were collected into microtubes and were used as extra-
cellular samples. These samples were stored at -80 °C.
CAM concentration in the supernatants and cell lysates
was measured using ion-paired high performance liquid
chromatography (HPLC) as follows. A 50 μl aliquot of
each cell supernatant or cell lysate was mixed with ethyl
4-aminobenzoate as an internal standard, which was
dissolved in acetonitrile (50 μl), and the mixture was
vortexed vigorously. After centrifugation at 12,000 × g
for 10 min, a 50-μl aliquot of the supernatant was ana-
lyzed by HPLC (Jasco Co., Tokyo, Japan) with a Mightysil
RP-18GP column (4.6 × 250 mm, 5 μm pore size; Kanto
Chemical Co., Tokyo, Japan). The mobile phase consisted
of 5 mM phosphate buffer (pH 3.5) and acetonitrile
(55:45) containing 5 mM 1-octanesulfonic acid as an ion-
paired reagent. The separation was performed at a flow
rate of 1.0 ml/min at 50 °C and was monitored at 210 nm
using an ultraviolet detector.
Statistical analysis
All data are expressed as means ± standard deviation
(SD). Statistical analysis was performed using one-way
analysis of variance (ANOVA), and differences, which
were estimated by Tukey’s multiple comparison test after
the Shapiro-Wilk test and Bartlett’s test, were considered
to be statistically significant at p < 0.05.
Results
Effects of CAM and H2O2 on SAEC cell growth
The WST-8 assay demonstrated that neither 1, 5 or 10 μM
of CAM nor 100 μM of H2O2 affected SAEC proliferation
or viability. No morphological changes were visible micro-
scopically in either resting SAECs or in these CAM- or
H2O2-treated cells. However, 30 μM of CAM significantly
inhibited the viability of SAECs at all time points assayed
(Fig. 1a and see Additional file 1, p < 0.01 vs. control), and
both 300 and 500 μM of H2O2 significantly induced cell
death at both 6 and 24 h after treatment (Fig. 1b and see
Additional file 2, p < 0.01 vs. control). Based on these data,
in the following experiments, H2O2 was used at a concen-
tration of 100 μM, and CAM was used at concentrations
of 1 or 5 μM (low) or 10 μM (high).
Effects of CAM pretreatment on H2O2-induced IL-8
protein release in SAECs
Normally cultured SAECs released low levels of IL-8
protein into the culture medium. The exposure of
SAECs to H2O2 (100 μM) caused a dramatic increase in
Fig. 1 Effects of CAM (a) and H2O2 (b) on cell viability in SAECs.
Cells were incubated with 1 μM, 5 μM, 10 μM or 30 μM CAM or with
100 μM, 300 μM, or 500 μM H2O2 for 72 or 24 h, respectively. Cell
viability was assessed by measuring formazan production from
viable cells (at 450 nm) as described in the Materials and Methods.
Data presented in panels a and b are means ± SD of six independent
experiments. **p < 0.01 vs. control cells
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SAECs with low or high concentrations of CAM for up
to 48 h prior to H2O2 treatment had no influence on
H2O2–induced IL-8 protein secretion. However, pre-
treatment with 1 or 5 μM CAM, but not with 10 μM
CAM, for 72 h prior to H2O2 treatment, significantly de-
creased H2O2-induced IL-8 protein release (p < 0.01)
(Fig. 2a and see Additional file 3). There was a signifi-
cant difference in secreted IL-8 protein level between
the low- and high-concentration CAM groups (p < 0.01).
These results showed that low-dose, long-term CAM
treatment could effectively suppress H2O2-induced IL-8
protein release in SAECs.
Effects of CAM pretreatment on H2O2-induced IL-8 mRNA
expression in SAECs
IL-8 mRNA expression in SAECs was significantly in-
creased by H2O2 treatment (100 μM) for 1 h. Similar to
its effects on H2O2-induced IL-8 release, pretreatment
with low or high concentrations of CAM for up to 48 h
had no effect on H2O2-induced IL-8 mRNA expression.
Notably, pretreatment with 1 or 5 μM CAM, but not
with 10 μM CAM, for 72 h significantly suppressed this
H2O2-induced IL-8 mRNA expression compared to
H2O2 treatment alone (p < 0.01) (Fig. 2b and seeAdditional file 4). Again, similar to the effect of CAM
on H2O2-induced IL-8 release, there was a significant
difference in H2O2-induced IL-8 mRNA expression be-
tween the low- and high-concentration CAM groups
(p < 0.01).
Effects of CAM pretreatment on H2O2-induced NF-κB
activation in SAECs
Using a specific oligonucleotide probe for NF-κB binding
sites in a transcription factor activity ELISA assay, the
nuclear extracts from resting SAECs showed NF-κB
binding activity. This binding activity in SAECs was sig-
nificantly increased by treatment with H2O2 (100 μM)
for 1 h. Pretreatment with CAM for up to 48 h had no
influence on this H2O2-induced NF-κB binding activity.
However, after 72 h pretreatment with 1 or 5 μM CAM,
but not with 10 μM CAM, H2O2-induced activation of
NF-κB was significantly decreased (p < 0.01) (Fig. 3a and
see Additional file 5). There was also a significant differ-
ence in H2O2-induced NF-κB binding activity between
the low- and high-concentration CAM groups (p < 0.01).
The above experimental results indicated that pretreat-
ment with CAM for up to 48 h had no influence on
H2O2-induced cellular disarrangements. Therefore, in
the following experiments, the effects of CAM on H2O2-
induced alterations in SAECs were examined following
CAM pretreatment for 72 h.
Effects of CAM on H2O2-induced IκBα phosphorylation in
SAECs
IκBα phosphorylation was significantly increased by
H2O2 treatment (100 μM) for 0.5 h as assessed by west-
ern blotting. Similar to its effects on NF-κB activation,
pretreatment with 1 or 5 μM CAM for 72 h significantly
suppressed this H2O2-induced phosphorylation com-
pared to H2O2 treatment alone (p < 0.01), whereas pre-
treatment with 10 μM CAM did not (Fig. 3b and see
Additional file 6). There was a significant difference in
H2O2-induced phosphorylation between the low- and
high-concentration CAM groups (p < 0.05 or p < 0.01, re-
spectively), similar to their effects on NF-κB activation.
Effects of CAM pretreatment on the H2O2-induced
GSH/GSSG ratio in SAECs
Incubation with H2O2 for 2 h significantly decreased the
GSH/GSSG ratio in SAECs compared to untreated cells
(p < 0.01). Pretreatment with a low concentration (1 or
5 μM), but not with a high concentration of CAM
(10 μM) for 72 h significantly increased this ratio in H2O2
treated cells (Fig. 4a and see Additional file 7, p < 0.01 vs.
H2O2 treatment alone). There was a significant difference
in the H2O2-induced GSH/GSSG ratio between the low-
and high-concentration CAM groups (p < 0.01). Fur-
thermore, these effects of CAM on the H2O2-induced
Fig. 2 Effects of CAM pretreatment on IL-8 protein (a) and mRNA (b) levels in H2O2-stimulated SAECs. In panel a, levels of IL-8 protein were
measured using the ELISA method. In panel b, IL-8 mRNA expression was measured using real-time RT-PCR. Samples were obtained from supernatants
(a) or cDNA (b) of control cells, of cells stimulated with 100 μM H2O2 alone, or of cells pretreated with 1 μM, 5 μM or 10 μM CAM for 24, 48 or 72 h
before stimulation with 100 μM H2O2 for 4 or 1 h, respectively. Data are presented as means ± SD of four independent experiments. *p < 0.05,
**p < 0.01 vs. control cells, ##p < 0.01 vs. cells stimulated with H2O2 alone,
††p < 0.01 vs. cells pretreated with 10 μM CAM
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H2O2-induced IL-8 protein release or IL-8 mRNA expres-
sion in SAECs as described above.
Effects of CAM pretreatment on H2O2-induced γ-GCS
protein expression in SAECs
The effects of CAM on H2O2-induced γ-GCS protein ex-
pression in SAECs was investigated using western blot-
ting. Exposure of SAECs to H2O2 (100 μM) significantly
increased γ-GCS protein expression versus control cells,
and this increased γ-GCS expression was maintained with
treatment with 1 or 5 μM CAM for 72 h before H2O2
treatment. However, pretreatment with 10 μM CAM for
72 h resulted in a significant decline in H2O2-induced γ-
GCS expression (Fig. 4b and see Additional file 8, p < 0.01
vs. H2O2 treatment alone). As expected, pretreatment with
a high concentration (10 μM) of CAM for 72 h also
significantly decreased H2O2-induced γ-GCS levelscompared to pretreatment with a low concentration (1 or
5 μM) of CAM for 72 h (p < 0.01).
Effects of CAM pretreatment on H2O2-induced Nrf2 mRNA
expression in SAECs
Nrf2 mRNA expression was significantly suppressed by
H2O2 treatment (100 μM) for 1 h. Similar to its effects
on the GSH/GSSG ratio, pretreatment with 1 or 5 μM
CAM, but not with 10 μM CAM, for 72 h significantly
increased Nrf2 mRNA expression in H2O2 treated cells
compared to H2O2 treatment alone (p < 0.01) (Fig. 5 and
see Additional file 9). As expected, there was a signifi-
cant difference in Nrf2 mRNA expression in H2O2
treated cells between the low- and high-concentration
CAM groups (p < 0.01). These effects of CAM on H2O2-
induced Nrf2 mRNA expression are the inverse of its
effects on H2O2-induced NF-κB activation or IκBα
phosphorylation in SAECs that are described above.
Fig. 3 Effects of CAM pretreatment on NF-κB (a) and p-IκBα (b) activation in SAECs stimulated with H2O2. In panel a, NF-κB activities were
measured using an ELISA method. In panel b, p-IκBα protein levels were detected by western blotting (upper, representative blot images; lower,
quantification of bands). Samples were obtained from nuclear proteins of control cells, of cells stimulated with 100 μM H2O2 alone, or of cells
pretreated with 1 μM, 5 μM or 10 μM CAM for 24, 48 or 72 h before stimulation with 100 μM H2O2 for 0.5–1 h. The data in panel b are of cells
preincubated with CAM for 72 h prior to H2O2 stimulation, and are expressed as the p-IκBα/β-actin ratio. Data are presented as means ± SD of
four independent experiments. *p < 0.05, **p < 0.01 vs. control cells, ##p < 0.01 vs. cells stimulated with H2O2 alone,
†p < 0.05, ††p < 0.01 vs. cells
pretreated with 10 μM CAM
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H2O2-treated cells
BSO inhibits γ-GCS to deplete cellular GSH. Pretreat-
ment of SAECs with BSO for 3 or 6 h aggravated the
loss of cell viability induced by treatment with 100 μM
H2O2 (Fig. 6a and see Additional file 10). Similarly, pre-
treatment with 10 μM CAM for 72 h before H2O2
(100 μM) treatment caused a significant decrease in cell
viability compared to H2O2 treatment alone (p < 0.01,
Fig. 6b and see Additional file 11). In contrast, the viabil-
ity of cells treated with H2O2 (100 μM) did not change
when pretreated with a low concentration (1 or 5 μM)of CAM. The low- and high-concentration CAM groups
differed significantly in their effects on the viability of
H2O2 treated cells, similar to their effect on γ-GCS
expression (p < 0.01, Fig. 6b and see Additional file 11).
Intracellular ROS levels
We next examined whether H2O2 modulation of intra-
cellular ROS levels was affected by pretreatment of the
cells with CAM. Intracellular ROS production was sig-
nificantly increased by H2O2 treatment (100 μM) for
0.25 h (p < 0.01 vs. control). However, pretreatment with
CAM (1, 5 or 10 μM) for 72 h had no effect on the
Fig. 4 Effects of CAM pretreatment on the GSH/GSSG ratio (a) and γ-GCS expression (b) in H2O2-stimulated SAECs. In panel a, GSH and GSSG
were determined using the DTNB recycling method. In panel b, γ-GCS expression was detected by western blotting (upper, representative blot
images; lower, quantification). Samples were obtained from supernatants (a) or cell pellets (b) of control cells, of cells stimulated with 100 μM
H2O2 alone, or of cells pretreated with 1 μM, 5 μM or 10 μM CAM for 72 h before stimulation with 100 μM H2O2 for 1–2 h. The data in panel
b are expressed as the γ-GCS/β-actin ratio. Data are presented as means ± SD of four independent experiments. **p < 0.01 vs. control cells,
##p < 0.01 vs. cells stimulated with H2O2 alone,
††p < 0.01 vs. cells pretreated with 10 μM CAM
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treatment alone (Fig. 7 and see Additional file 12).
Extra- and intracellular CAM concentrations
We performed HPLC analysis of extracellular and intra-
cellular levels of CAM to evaluate the stability of CAM
in the culture medium and the amount of CAM that en-
tered into the SAECs. Under the analytical conditions
used, no peaks other than CAM were eluted on the
chromatogram. The concentration of CAM in culture
supernatants decreased in a time-dependent manner(Fig. 8a and see Additional file 13). Conversely, CAM
levels in the cells increased in a time-dependent manner
(Fig. 8b and see Additional file 14). The levels of intra-
cellular CAM in the cells treated with 5 or 10 μM CAM
were the same for up to 48 h of CAM treatment. How-
ever, after 72 h of treatment the intracellular CAM con-
centration in the cells treated with 10 μM CAM was
significantly higher (p < 0.05) than that of the cells
treated with 5 μM CAM. There was a significant differ-
ence in intracellular CAM concentration between the
low- and high-concentration CAM groups after 72 h of
Fig. 5 Effects of CAM on Nrf2 mRNA expression in SAECs stimulated
with H2O2. Nrf2 mRNA was measured using real-time RT-PCR. Samples
were obtained from cell pellets of control cells, of cells stimulated with
100 μM H2O2 alone, or of cells pretreated with 1 μM, 5 μM or 10 μM
CAM for 72 h before stimulation with 100 μM H2O2 for 1 h. Data are
presented as means ± SD of four independent experiments. **p < 0.01
vs. control cells, ##p < 0.01 vs. cells stimulated with H2O2 alone,
††p < 0.01 vs. cells pretreated with 10 μM CAM
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groups (p < 0.01) at all time points.
Discussion
The anti-inflammatory effects of macrolide antibiotics were
first discovered in clinical practice [1], and much basic re-
search has been subsequently reported [36]. However, the
mechanism of action of low-dose, long-term therapy on
airway inflammation remains unclear. Therefore, in this
study, we examined the cytoprotective action of CAM
against H2O2-induced cellular dysfunction (focusing on
dose and duration) in SAECs, which are the main cell type
involved in chronic inflammatory airway diseases.
First, we examined cell viability to identify sub-toxic
concentrations for CAM and H2O2. Based on the results
of those experiments, we used 1 and 5 μM CAM as the
low-dose pretreatment, and 10 μM CAM as the high-
dose pretreatment (Fig. 1). These CAM concentrations
were deemed reasonable because an adult taking 200 mg
of CAM per day (low dose) would exhibit CAM levels of
approximately 1–5 μM in blood as well as in bronchial
epithelial lining fluid [37], compared to approximately
11 μM with an intake of 400 mg per day (normal dose).
Furthermore, during inflammatory conditions in the
lower respiratory tract, neutrophil-derived H2O2 in re-
spiratory tract viscous fluid is reported to reach a con-
centration of 50 μM [38]. Since H2O2 is also produced
directly from bronchial epithelial cells following stimula-
tion with pollutants such as bacteria and LPS [39], it is
thought that the 100 μM H2O2 concentration used in
this study reflects conditions observed during chronic
inflammatory airway diseases.Our study confirmed that CAM decreased H2O2-
induced IL-8 protein release in SAECs (Fig. 2a). This de-
crease was associated with inhibited expression of IL-8
mRNA and suppression of transcription factor NF-κB
activity (Figs. 2b and 3a). Among the cytokines reduced by
macrolides, IL-8 was negatively regulated in most studies
of airway epithelial cells, neutrophils, and monocytes
[27–29]. In this study, however, it is clearly shown that
CAM inhibited IL-8 synthesis after long-term treatment
with a low dose, but not after a short-term treatment or
treatment with a high dose. In addition, the phosphoryl-
ation of IκBα, which inactivates NF-κB in the cytoplasm,
was also suppressed by long-term, low-dose CAM treat-
ment, but not by a high CAM concentration (Fig. 3b). It is
therefore thought that the inhibition of NF-κB activity is
linked to inhibition of IκBα phosphorylation by CAM.
There is a possibility that long-term, low-dose treatment
with CAM has an effect on other inflammatory cytokines
(such as IL-6) that are also regulated by NF-κB, similar to
its effect on IL-8. Additionally, it was reported that the
14-OH metabolite of CAM strongly inhibited IL-8 pro-
duction induced by tumor necrosis factor (TNF)-α in
bronchial epithelial cells [40]. Although the 14-OH metab-
olite was not found in our HPLC analysis, it will be neces-
sary to examine its influence on NF-κB activity in future
studies.
In chronic inflammatory airway diseases, patients de-
velop oxidant/antioxidant imbalance. The antioxidant
GSH plays an important role in the development of oxi-
dative stress tolerance. GSH is reduced by oxidation to
the GSSG form, and reduction of the GSH/GSSG ratio
causes chronic airway inflammation [41]. However, the
effects of CAM on antioxidant status remain unclear.
Rapid impairment of the GSH/GSSG ratio and rapid in-
duction of intracellular GSH synthesis in SAECs were
observed in response to H2O2-induced oxidative stress.
These rapid changes may imply a critical determinant of
cellular tolerance to oxidative stress [42]. Since SAECs
are cells that directly contact the external environment,
it is believed that these cells are more highly sensitive to
oxidative stress compared to endothelial cells [43]. In
this study, the GSH/GSSG ratio was significantly
increased by long-term treatment with low CAM con-
centrations, which contributed to the improvement of
oxidant/antioxidant imbalance (Fig. 4a). On the other
hand, the expression of γ-GCS protein, a GSH synthesis
enzyme, was significantly suppressed by treatment with
long-term, high-dose CAM (Fig. 4b). It has been re-
ported that H2O2-induced GSH production and γ-GCS
expression in bronchial epithelial cells is suppressed by
pretreatment with EM (5 μg/ml; ca. 6.8 μM) for 48 h,
resulting in disturbance of the oxidant/antioxidant
balance [25]. However, the effects of lower EM concen-
trations and longer incubation times were not examined.
Fig. 6 Effects of BSO (a) and CAM (b) on cell viability in SAECs stimulated with H2O2. In panel a, samples were obtained from control cells, or
from cells pretreated with or without 1 mM BSO for 16 h before stimulation with 100 μM H2O2 for 1, 3 or 6 h. In panel b, samples were obtained
from control cells, from cells stimulated with 100 μM H2O2 alone, or from cells pretreated with 1 μM, 5 μM or 10 μM CAM for 72 h before
stimulation with 100 μM H2O2 for 3 h. Data are presented as means ± SD of six independent experiments. *p < 0.05, **p < 0.01 vs. control cells,
##p < 0.01 vs. cells stimulated with H2O2 alone,
††p < 0.01 vs. cells pretreated with 10 μM CAM
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treatment with a low CAM concentration (1 or 5 μM)
increased γ-GCS expression to improve the oxidant/
antioxidant imbalance. Nevertheless, the reason why
γ-GCS expression was suppressed by treatment with a
high CAM concentration (10 μM) for a long duration re-
mains to be elucidated. Although γ-GCS expression is not
accompanied by changes in NF-κB activity [44], the
change in the GSH/GSSG ratio that is brought about by
low CAM concentrations in this study appears to be in
the inverse direction to the change brought about in
NF-κB activation or IκBα phosphorylation. ROS causes
increased gene expression of both proinflammatory genes
and the protective gene γ-GCS by oxidant-mediated acti-
vation of transcription factors. Other transcription factors
connected with NF-κB activation might be related to GSH
production during oxidative stress [45]. Nrf2 is animportant transcription factor that regulates GSH levels
by controlling the expression of the γ-GCS gene [21].
Moreover, it is also reported that Nrf2 inhibited NF-κB
activation in response to Nrf2 activities in vascular endo-
thelial cells [30, 31]. Indeed, consistent with these reports,
we clearly demonstrated that Nrf2 mRNA expression was
increased to suppress NF-κB activation at low concentra-
tions of CAM but not at a high concentration of CAM
(Fig. 5). An increase in Nrf2 expression stimulates γ-GCS
gene expression to increase the intracellular GSH level.
Accordingly, it is considered that γ-GCS expression was
suppressed in the case of treatment with a high CAM
concentration for a long duration (Fig. 4b). However, for
better understanding of the involvement of Nrf2 in GSH
production after treatment with CAM, the effects of using
knock-down and inhibitors of Nrf2 need to be examined
in more detail in future studies. The culture medium used
Fig. 7 Effects of CAM on intracellular ROS levels in SAECs stimulated
with H2O2. Intracellular ROS levels were measured using flow cytometry
with the fluorescent probe CDF. Samples were obtained from control
cells, from cells stimulated with 100 μM H2O2 alone, or from cells
pretreated with 1 μM, 5 μM or 10 μM CAM for 72 h before stimulation
with 100 μM H2O2 for 0.25 h. CDF (1 μM) was applied to cells for 0.25 h
before stimulation with H2O2. Data are presented as means ± SD of four
independent experiments. **p < 0.01 vs. control cells
Fig. 8 Time-dependent changes in extracellular (a) and intracellular (b) concen
or 10 μM CAM for 24, 48 or 72 h. CAM concentrations were measured using H
*p < 0.05, **p< 0.01 vs. cells incubated with the same concentration of CAM fo
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(15 ng/mL) to prevent microbial contamination. Both GM
and AMTB have been shown to induce changes in oxidant/
antioxidant imbalance at concentrations of 10 mg/mL and
0.7–1.9 μg/mL, respectively, in vivo [46, 47]. However, since
the concentrations of these agents in the medium used in
the experiments of this study were about 50- to 300-fold
lower than the values previously reported to modulate the
oxidant/antioxidant balance, it is considered that the
addition of these agents to the medium did not affect the
oxidant/antioxidant balance in our experiments.
We further explored the relationship between γ-GCS
activity and cell viability to determine the influence of
γ-GCS suppression following long-term pretreatment
with a high CAM concentration. Exposure to BSO
resulted in increased H2O2-induced cytotoxicity in SAECs
(Fig. 6a). This result indicates that cell viability is
decreased when γ-GCS synthesis is suppressed during
oxidative stress. This result means that intracellular GSH
plays a critical role during H2O2-induced cytotoxicity in
SAECs. However, in contrast to the effect of low-dosetrations of CAM in SAECs. Cells were incubated with 1 μM, 5 μM
PLC. Data are presented as means ± SD of four independent experiments.
r 0 h. †p < 0.05, ††p < 0.01 vs. cells incubated with 10 μM CAM at each time
Iwayama et al. BMC Pharmacology and Toxicology  (2017) 18:15 Page 13 of 15CAM, H2O2-induced cytotoxicity was not prevented by
long-term pretreatment of SAECs with a high CAM con-
centration (Fig. 6b). Long-term pretreatment with a high
CAM concentration may induce a disturbance similar to
that induced by BSO in SAECs during oxidative stress.
CAM was not shown to have a direct radical scavenger
activity against ROS (Fig. 7). Thus, low concentrations
(1 and 5 μM) of CAM do not directly inhibit intracellu-
lar ROS, but instead indirectly inhibit the cell damage
caused by ROS by activating a system that modulates
the damaging effects of H2O2 by improving the GSH/
GSSG ratio. Nevertheless, the effects of CAM are not
observed in cells pretreated with CAM for 48 h but only
become evident after a further 24 h of pretreatment, i.e.,
after a total of 72 h of pretreatment. The mechanism
underlying the difference between the effects of pretreat-
ment with CAM for 48 h and those of pretreatment with
CAM for 72 h remains unclear. Although it has been re-
ported that the influx of CAM into epithelial cells is
completed within 5 min [48], in the present study the
levels of intracellular CAM gradually changed over time
and did not reach a plateau until after 72 h incubation
of the cells with CAM (Fig. 8). The results showed that
the cells incubated with 10 μM CAM had a significantly
higher intracellular CAM concentration compared to
the cells incubated with 5 μM CAM. Since EM has been
found to exacerbate the oxidant/antioxidant balance in
cells when the concentration in the extracellular fluid
exceeds 6.8 μM [25], it is possible that the same changes
occur in cells during pretreatment with 10 μM CAM,
through an unknown mechanism. A decrease in Nrf2
activity might be involved in this mechanism.
There is no evidence to indicate whether the exposure
of cells to CAM for 24, 48 or 72 h can be a model for the
effect of short-term or long-term administration of CAM
in the clinical setting. Furthermore, it is difficult to explain
the difference between its effects on cells and its effects in
clinical treatments. Nevertheless, low-dose, long-term
clinical administration of CAM is believed to enhance
anti-oxidative defense reactions during periods of oxida-
tive stress. On the other hand, there is the problem that
low-dose, long-term therapy of CAM would encourage
the development of CAM-resistant pathogens and mico-
flora [49]. However, the usefulness and feasibility of CAM
therapy lies in its anti-inflammatory effect rather than in
its antimicrobial action [50]. Therefore, if, in addition to
its anti-inflammatory effect CAM therapy also results in
induction of CAM-resistant bacteria, the risk of such an
increase in resistant bacteria could be reduced with the
combined use of other antibacterial agents.
Conclusions
This study showed that low-dose, long-term CAM treat-
ment could inhibit H2O2-induced IL-8 production bysuppressing transcription factor NF-κB activation in
SAECs, and could inhibit H2O2-induced reduction of
the GSH/GSSG ratio in SAECs via the maintenance of
GSH levels through an effect on γ-GCS expression that
was associated with Nrf2 mRNA expression. These data
indicate that CAM is efficacious against cell dysfunction
caused by oxidative stress under low-dose, long-term
treatment conditions. Although it is not possible to dir-
ectly translate a pharmacological effect on cells to treat-
ment efficacy in clinical practice, the present study
presents the first possible evidence of why low-dose,
long-term macrolide therapy is effective against chronic
inflammatory airway diseases.
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